Viewing Study NCT04802057


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-02-21 @ 6:45 PM
Study NCT ID: NCT04802057
Status: TERMINATED
Last Update Posted: 2025-09-11
First Post: 2021-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088
Sponsor: Bioverativ, a Sanofi company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Haemolytic Anaemia View
Keywords: